Mathur Mahesh, Thakur Neha, Jaiswal Sunil, Maharjan Srijana, Paudel Supriya, Shrestha Anjali
Department of Dermatology, Venereology, and Leprology College of Medical Sciences and Teaching Hospital Bharatpur Nepal.
Clin Case Rep. 2023 Oct 9;11(10):e8027. doi: 10.1002/ccr3.8027. eCollection 2023 Oct.
Toxic epidermal necrolysis (TEN) is a dermatologic emergency usually attributed to drugs. Recurrent episodes of TEN are more common in the pediatric population than in adults. Patients carrying susceptible specific haplotypes, cross-reactivity between the drugs, and drug metabolites generated by the Cytochrome P450 are the key factors for the recurrent episodes. Chronic kidney disease (CKD) increases the risk of toxic epidermal necrolysis by altering the pharmacokinetics and pharmacodynamics of the drug with comparatively higher mortality in this group of patients. We hereby present an elderly female with 2 episodes of TEN following intake of furosemide at present and Nimesulide 3 years back. Cross-reactivity between these drugs because of the similar stereochemical structure might have triggered the second episode. The second episode of TEN was milder in presentation with a short latency period without any constitutional symptoms as compared to the first episode. Thus, treating physicians should always consider cross-reactivity between the chosen drugs in order to prevent subsequent life-threatening episodes, especially in patients with CKD.
中毒性表皮坏死松解症(TEN)是一种通常由药物引起的皮肤科急症。TEN的复发在儿科人群中比在成人中更常见。携带易感特定单倍型、药物之间的交叉反应以及细胞色素P450产生的药物代谢产物是复发的关键因素。慢性肾脏病(CKD)通过改变药物的药代动力学和药效学增加了中毒性表皮坏死松解症的风险,在这组患者中死亡率相对较高。我们在此报告一名老年女性,目前因服用呋塞米出现2次TEN发作,3年前因服用尼美舒利也曾发作过。由于相似的立体化学结构,这些药物之间的交叉反应可能引发了第二次发作。与第一次发作相比,第二次TEN发作表现较轻,潜伏期短,无任何全身症状。因此,治疗医生应始终考虑所选药物之间的交叉反应,以防止随后危及生命的发作,尤其是在CKD患者中。